What changed
$MOH — BUY 📊
Molina Healthcare, Inc.
🎯 Q1 FY26 | Rev $11B | EPS $2.35 vs $1.91 🟢
💡 Consensus sees $5.00–$5.20 as full‑year EPS, implying the beat was pull‑forward or one‑off. The variant view is that underlying membership stability and medical cost improvements are durable, making $5.50+ readily achievable and $6.00+ in a bull case. The market’s low single‑digit P/E off depressed earnings fails to price the rebound.
📉 Reward/Risk: 2.2:1
🏢 Business Quality: 6/10 - Molina is a well‑run managed‑care player focused on Medicaid, but margins are thin and the business is exposed to regulatory change. The low current profitability masks a reasonably resilient franchise.
📊 Valuation: rich on near‑term depressed P/E (~39×); fair on normalized EPS (~19–20× vs. peers at 14–18×); EV/EBITDA likely high given thin margins — overall fair...
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/MOH0618